{"issuance_frequency":"","notes_translated":{"fr":"Ce document vise à fournir aux promoteurs qui soumettent une présentation de drogue nouvelle et une présentation abrégée de drogue nouvelle les renseignements dont ils ont besoin pour se conformer à l’alinéa C.08.002(2)(h), au sous-alinéa C.08.002.1(2)(c)(ii) et au paragraphe C.08.003(3) du Règlement sur les aliments et drogues en ce qui concerne les études pharmacocinétiques comparatives, en particulier les études in vivo","en":"The purpose of this document is to provide sponsors of new drug submissions and abbreviated new drug submissions with the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations, with respect to comparative pharmacokinetic studies, with emphasis on in vivo comparative pharmacokinetic studies."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"c132ff32-6522-44ce-9058-eff626523651","metadata_created":"2021-06-02T18:42:17.953707","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-02T18:42:17.953713","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-02","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["ébauche de directives","consultation","études pharmacocinétiques comparatives","produits inhalés par voie orale","promoteurs de présentations de drogues nouvelles","présentations de drogues nouvelles abrégées","Règlement sur les aliments et drogues"],"en":["draft guidance","consultation","comparative pharmacokinetic studies","orally inhaled products","sponsors of new drug submissions","abbreviated new drug submissions","Food and Drug Regulations"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Avis : Publication de l’ébauche de la ligne directrice aux fins de consultation : Études pharmacocinétiques comparatives sur les produits administrés par inhalation orale","en":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"c132ff32-6522-44ce-9058-eff626523651","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"7185ba90-f963-4113-9ce5-61ad1d117aba","related_relationship":"","name_translated":{"fr":"Avis : Publication de l’ébauche de la ligne directrice aux fins de consultation : Études pharmacocinétiques comparatives sur les produits administrés par inhalation orale","en":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products","language":["en"],"created":"2021-06-02T18:42:18.028783","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/public-involvement-consultations/notice-draft-guidance-comparative-pharmacokinetic-studies-orally-inhaled-products.html","last_modified":null,"position":0,"revision_id":"2d68959c-2fcc-44f8-9dc0-d0b9e4937224","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"c132ff32-6522-44ce-9058-eff626523651","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9b209ee2-a415-4436-ac5b-7948d488a31c","related_relationship":"","name_translated":{"fr":"Avis : Publication de l’ébauche de la ligne directrice aux fins de consultation : Études pharmacocinétiques comparatives sur les produits administrés par inhalation orale","en":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products","language":["fr"],"created":"2021-06-02T18:42:18.028788","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/participation-public-consultations/medicaments/avis-ebauche-ligne-directrice-etudes-pharmacocinetiques-comparatives-produits-administres-inhalation-orale.html","last_modified":null,"position":1,"revision_id":"2d68959c-2fcc-44f8-9dc0-d0b9e4937224","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-02-27 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"c132ff32-6522-44ce-9058-eff626523651","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this document is to provide sponsors of new drug submissions and abbreviated new drug submissions with the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations, with respect to comparative pharmacokinetic studies, with emphasis on in vivo comparative pharmacokinetic studies.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice: Release of Draft Guidance Document for Consultation: Comparative Pharmacokinetic Studies for Orally Inhaled Products","revision_id":"2d68959c-2fcc-44f8-9dc0-d0b9e4937224"}